Five-year survival results: Frontline brentuximab vedotin in combination with CHP in patients with CD30-expressing peripheral T-cell lymphomas Meeting Abstract
| Authors: | Fanale, M. A.; Horwitz, S. M.; Forero-Torres, A.; Bartlett, N. L.; Advani, R. H.; Pro, B.; Chen, R. W.; Davies, A.; Illidge, T. M.; Uttarwar, M.; Huebner, D.; Ren, H.; Shustov, A. R. |
| Abstract Title: | Five-year survival results: Frontline brentuximab vedotin in combination with CHP in patients with CD30-expressing peripheral T-cell lymphomas |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419407020 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.2790.2790 |
| Notes: | Meeting Abstract: 2790 -- Source: Wos |
